Trial Profile
The Pharmacokinetic Interaction Between Metformin and Nizatidine in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Nizatidine (Primary)
- Indications Gastro-oesophageal reflux; Peptic ulcer; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 23 Mar 2013 Status changed from active, no longer recruiting to completed.
- 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 24 Sep 2012 Planned End Date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.